ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.

The HBeAg Test detects the presence of Hepatitis B e Antigen in the blood, indicating active viral replication and increased infectivity.

The test is used to diagnose active Hepatitis B infection, monitor disease progression, guide treatment decisions, and evaluate treatment effectiveness.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 1 to 3 days after the test.

A positive result indicates active Hepatitis B virus replication and increased infectivity, suggesting that the virus is actively replicating in the body.

Candidates include individuals with significant nasal obstruction or breathing difficulties caused by a deviated septum that does not improve with other treatments.